Showing results (391-400 of 598) with videos related to
Sort By:
Pageof 60
CNS & Neurological Disorders Drug Targets|April 10, 2012
Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's diseaseZhen Zhang, Xuping Li, Wen-jie Xie, et al.Neurology|January 19, 2018
Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled studyWilliam G Ondo, Jerald H Simmons, Muhammad H Shahid, et al.Neurological Research|August 24, 2017
Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regionsIsil Ezgi Eryilmaz, Gulsah Cecener, Sevda Erer, et al.Autoimmunity|September 17, 2010
Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian AmericansPhilip R Deitiker, Minako Oshima, Joseph Jankovic, et al.Journal of the Neurological Sciences|December 17, 2003
Clinical gait and balance scale (GABS): validation and utilizationMadhavi Thomas, Joseph Jankovic, Monthaporn Suteerawattananon, et al.Journal of Neuroimmunology|November 15, 2011
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/BMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.Journal of Obsessive-Compulsive and Related Disorders|December 2, 2014
Progress in research on Tourette syndromeKevin J Black, Joseph Jankovic, Tamara Hershey, et al.Parkinsonism & Related Disorders|April 3, 2010
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystoniaDaniel Truong, Matthew Brodsky, Mark Lew, et al.Journal of Neuroimmunology|July 9, 2011
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patientsMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.Parkinsonism & Related Disorders|February 15, 2011
Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulationAmy E Williams, Gladys Marina Arzola, Adriana M Strutt, et al.Pageof 60